BIOTECH TEMPERATURE RISES
Investors are showing classic symptoms of biotech fever.
They’re seizing on good news about drug trials, cheering new drug-related news and buying shares contagiously…
Science and Law: Swapping the lab for the law
For scientists who want a career in law, the options are greater than ever – and some don’t even involve going back to school
Biotech sector keeps surging / Cancer drug news and FDA approvals create optimism
Industry observers say the sector’s sea change from pessimism to optimism comes from two sources: Good news about experimental cancer drugs from a major scientific meeting this month; and a set of recent approvals by the Food and Drug Administration, whose new leadership is seen as more company-friendly.
Early stage biotechnology collaborations
The range of deals an early stage biotechnology company may enter into is wide (see box ‘What is an early stage biotechnology collaboration?’). This chapter examines, by reference to a few of the types of agreements that an early stage company may enter into, some of the key intellectual property (IP) and other legal issues that arise when undertaking such deals